Healthcare Services

Hereditary Testing Market Outlook 2026–2030 Exploring New Business Opportunities

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Hereditary Testing Market Expected To Change Between 2026 And 2030?

The hereditary testing market has experienced robust growth in recent years. It is anticipated to increase from $6.62 billion in 2025 to $7.23 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. This historical expansion can be linked to improvements in genetic sequencing technologies, a rise in awareness regarding inherited disorders, the broadening of clinical genetics programs, a decrease in the cost of genetic testing, and the proliferation of diagnostic laboratory networks.

The hereditary testing market is projected to experience significant expansion in the coming years, with its size expected to reach $10.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This anticipated growth can be attributed to several factors within the forecast period, including the increasing incorporation of genomics into routine medical practices, a rising demand for precision medicine applications, the broadening of population-scale genetic screening initiatives, the expanding utilization of digital genetic data platforms, and a greater emphasis on preventive healthcare genomics. Throughout the forecast period, major trends are set to include the growing adoption of next-generation sequencing tests, an escalating requirement for predictive and carrier genetic testing, increased application of AI-based variant interpretation, the enlargement of prenatal and newborn screening programs, and an enhanced focus on personalized genetic counseling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25782&type=smp

Which Major Factors Are Driving The Expansion Of The Hereditary Testing Market?

The expanding occurrence of genetic disorders is projected to boost the growth of the hereditary testing market in the coming years. Genetic disorders are health conditions resulting from irregularities or changes in an individual’s deoxyribonucleic acid, which can be passed down from one or both parents or emerge without prior inheritance. The surge in genetic disorders is partly attributed to older parental age, increasing the probability of genetic mutations being transferred to offspring. Hereditary testing assists patients with genetic disorders by facilitating early detection, directing personalized medical approaches, and aiding family planning decisions through the identification of inherited genetic alterations. For example, as reported by the UK-based charitable organization, Cystic Fibrosis Trust, in October 2024, the count of individuals registered with cystic fibrosis increased to 11,318 in 2023, up from 11,148 in 2022. Thus, the rising prevalence of genetic disorders is stimulating the expansion of the hereditary testing market.

How Is The Hereditary Testing Market Structured Across Different Segments?

The hereditary testing market covered in this report is segmented –

1) By Test Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Testing, Other Test Types

2) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Buccal Swabs, Amniotic Fluid And Cord Blood Samples

3) By Technology Used: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Sanger Sequencing, Microarray Technology, Whole Genome Sequencing (WGS)

4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders, Other Applications

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Patients And Consumers

Subsegments:

1) By Predictive Testing: Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Gene Mutation Testing, Lynch Syndrome Testing, Familial Hypercholesterolemia Testing, Huntington’s Disease Testing, Cardiomyopathy Genetic Testing

2) By Carrier Testing: Cystic Fibrosis Carrier Screening, Tay-Sachs Carrier Screening, Spinal Muscular Atrophy (SMA) Carrier Screening, Thalassemia Carrier Screening, Sickle Cell Carrier Testing

3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT), Chorionic Villus Sampling (CVS), Amniocentesis, Expanded Carrier Screening (Prenatal Context), Cell-Free Fetal Deoxyribonucleic Acid Testing

4) By Newborn Screening: Phenylketonuria (PKU) Screening, Congenital Hypothyroidism Screening, Cystic Fibrosis Screening, Sickle Cell Disease Screening, Hearing Loss and Metabolic Disorder Panels

5) By Diagnostic Testing: Rare Disease Genetic Testing, Inherited Cancer Diagnostic Testing, Cardiogenetic Diagnostic Panels, Neurogenetic Disorder Testing, Monogenic Disease Panels

6) By Other Test Types: Pharmacogenomics Testing, Preimplantation Genetic Diagnosis (PGD), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), Mitochondrial Deoxyribonucleic Acid Testing

Which Trends Are Shaping The Future Of The Hereditary Testing Market?

Leading companies in the hereditary testing market are focusing on technological advancements in genetic test kits to improve testing accuracy, reduce turnaround times, and enhance the detection of a broader range of genetic mutations. Genetic test kits are diagnostic tools used to analyze an individual’s DNA to identify mutations or variations associated with inherited conditions or disease risks. For example, in July 2023, Devyser Diagnostics AB, a Sweden-based biotechnology company specializing in the development, manufacturing, and sale of DNA diagnostic kits for hereditary disease testing, launched two targeted next-generation sequencing kits: Devyser LynchFAP and Devyser BRCA PALB2. Devyser LynchFAP enables comprehensive analysis of PMS2, addressing challenges caused by its pseudogene PMS2CL, along with nine additional key genes linked to hereditary colorectal cancer syndromes. Meanwhile, Devyser BRCA PALB2 provides a streamlined, single-tube solution for detecting BRCA1, BRCA2, and PALB2 mutations in both blood and tumor samples. These solutions are designed to simplify laboratory workflows by offering efficient, user-friendly sequencing along with dedicated software, enabling accurate identification of hereditary cancer risks.

Which Major Players Dominate The Hereditary Testing Market?

Major companies operating in the hereditary testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., CooperSurgical Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, GeneDx LLC, Twist Bioscience Corporation, Color Health Inc., MedGenome Inc, SOPHiA GENETICS SA, Gene By Gene Ltd., Dante Labs Inc., 23mofang Co. Ltd.

Read the full hereditary testing market report here:

https://www.thebusinessresearchcompany.com/report/hereditary-testing-global-market-report

Which Region Currently Holds The Largest Share Of The Hereditary Testing Market?

North America was the largest region in the hereditary testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hereditary Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25782&type=smp

Browse Through More Reports Similar to the Global Hereditary Testing Market 2026, By The Business Research Company

Genetic Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Dna Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Prenatal And Newborn Genetic Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795